SE515668C2 - Metod och kit för tidig förutsägelse av cancer - Google Patents
Metod och kit för tidig förutsägelse av cancerInfo
- Publication number
- SE515668C2 SE515668C2 SE9900615A SE9900615A SE515668C2 SE 515668 C2 SE515668 C2 SE 515668C2 SE 9900615 A SE9900615 A SE 9900615A SE 9900615 A SE9900615 A SE 9900615A SE 515668 C2 SE515668 C2 SE 515668C2
- Authority
- SE
- Sweden
- Prior art keywords
- hpv
- specific
- nucleic acid
- dna
- human
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 9
- 201000011510 cancer Diseases 0.000 title claims abstract description 9
- 230000003612 virological effect Effects 0.000 claims abstract description 35
- 239000000523 sample Substances 0.000 claims abstract description 33
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 17
- 206010008342 Cervix carcinoma Diseases 0.000 claims abstract description 16
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims abstract description 16
- 201000010881 cervical cancer Diseases 0.000 claims abstract description 16
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 6
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 6
- 241000700605 Viruses Species 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 26
- 241000701806 Human papillomavirus Species 0.000 claims description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 8
- 238000011065 in-situ storage Methods 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 238000003752 polymerase chain reaction Methods 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 231100000590 oncogenic Toxicity 0.000 claims description 5
- 230000002246 oncogenic effect Effects 0.000 claims description 5
- 101150029662 E1 gene Proteins 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 210000004392 genitalia Anatomy 0.000 claims description 3
- 101150071673 E6 gene Proteins 0.000 claims description 2
- 101150013359 E7 gene Proteins 0.000 claims description 2
- 101150075239 L1 gene Proteins 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 238000009830 intercalation Methods 0.000 claims description 2
- 238000005259 measurement Methods 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims 1
- 230000004544 DNA amplification Effects 0.000 abstract description 2
- 238000012197 amplification kit Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 108010085238 Actins Proteins 0.000 description 15
- 102000007469 Actins Human genes 0.000 description 15
- 108091093105 Nuclear DNA Proteins 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000007477 logistic regression Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical class N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 101100069818 Caenorhabditis elegans gur-3 gene Proteins 0.000 description 1
- 101100289200 Caenorhabditis elegans lite-1 gene Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101000834258 Takifugu rubripes Actin, cytoplasmic 3 Proteins 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Machine Translation (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9900615A SE515668C2 (sv) | 1999-02-22 | 1999-02-22 | Metod och kit för tidig förutsägelse av cancer |
| EP00909879A EP1155153B1 (de) | 1999-02-22 | 2000-02-22 | Verfahren und kit zur früherkennung von krebs |
| JP2000601208A JP5546085B2 (ja) | 1999-02-22 | 2000-02-22 | 早期がん予測のための方法及びキット |
| DE60025336T DE60025336T2 (de) | 1999-02-22 | 2000-02-22 | Verfahren und kit zur früherkennung von krebs |
| PCT/SE2000/000350 WO2000050645A1 (en) | 1999-02-22 | 2000-02-22 | Method and kit for early cancer prediction |
| AT00909879T ATE315107T1 (de) | 1999-02-22 | 2000-02-22 | Verfahren und kit zur früherkennung von krebs |
| CA2367833A CA2367833C (en) | 1999-02-22 | 2000-02-22 | Method and kit for early cancer prediction |
| AU32056/00A AU3205600A (en) | 1999-02-22 | 2000-02-22 | Method and kit for early cancer prediction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9900615A SE515668C2 (sv) | 1999-02-22 | 1999-02-22 | Metod och kit för tidig förutsägelse av cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9900615D0 SE9900615D0 (sv) | 1999-02-22 |
| SE9900615L SE9900615L (sv) | 2000-08-23 |
| SE515668C2 true SE515668C2 (sv) | 2001-09-17 |
Family
ID=20414574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9900615A SE515668C2 (sv) | 1999-02-22 | 1999-02-22 | Metod och kit för tidig förutsägelse av cancer |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1155153B1 (de) |
| JP (1) | JP5546085B2 (de) |
| AT (1) | ATE315107T1 (de) |
| AU (1) | AU3205600A (de) |
| CA (1) | CA2367833C (de) |
| DE (1) | DE60025336T2 (de) |
| SE (1) | SE515668C2 (de) |
| WO (1) | WO2000050645A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10009143B4 (de) * | 2000-02-26 | 2012-04-26 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Nachweis von Humanen Papillomviren |
| GB0207242D0 (en) * | 2002-03-27 | 2002-05-08 | Norchip As | Universal detection of human papillomavirus mRNA |
| ATE289685T1 (de) * | 2003-08-25 | 2005-03-15 | Mtm Lab Ag | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben |
| EP1819835B1 (de) | 2004-12-08 | 2010-08-04 | Gen-Probe Incorporated | Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus |
| WO2007115582A1 (en) * | 2006-04-11 | 2007-10-18 | Bio-Rad Pasteur | Hpv detection and quantification by real-time multiplex amplification |
| DE102006041970A1 (de) * | 2006-08-28 | 2008-03-06 | Genome Identification Diagnostics Gmbh | Verfahren und Mittel zum Nachweis von humanen Papillomaviren |
| CN103314117B (zh) * | 2010-05-05 | 2016-08-17 | 德国癌症研究中心 | 在不同的宫颈病变中的hr-hpv的诊断转录物和剪接模式 |
| CN109593755A (zh) * | 2018-12-29 | 2019-04-09 | 北京优迅医学检验实验室有限公司 | 一种用于提取保存的动物样品中基因组dna的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain |
| US5182377A (en) * | 1988-09-09 | 1993-01-26 | Hoffmann-La Roche Inc. | Probes for detection of human papillomavirus |
| DE69033850T2 (de) * | 1989-12-01 | 2002-06-06 | Vysis, Inc. | Nukleinsäuresonden zum Nachweis von HPV-Transkripts |
-
1999
- 1999-02-22 SE SE9900615A patent/SE515668C2/sv not_active IP Right Cessation
-
2000
- 2000-02-22 AT AT00909879T patent/ATE315107T1/de not_active IP Right Cessation
- 2000-02-22 DE DE60025336T patent/DE60025336T2/de not_active Expired - Lifetime
- 2000-02-22 AU AU32056/00A patent/AU3205600A/en not_active Abandoned
- 2000-02-22 CA CA2367833A patent/CA2367833C/en not_active Expired - Lifetime
- 2000-02-22 JP JP2000601208A patent/JP5546085B2/ja not_active Expired - Lifetime
- 2000-02-22 EP EP00909879A patent/EP1155153B1/de not_active Expired - Lifetime
- 2000-02-22 WO PCT/SE2000/000350 patent/WO2000050645A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU3205600A (en) | 2000-09-14 |
| DE60025336D1 (de) | 2006-03-30 |
| EP1155153B1 (de) | 2006-01-04 |
| DE60025336T2 (de) | 2006-11-30 |
| CA2367833A1 (en) | 2000-08-31 |
| JP5546085B2 (ja) | 2014-07-09 |
| CA2367833C (en) | 2012-11-20 |
| SE9900615D0 (sv) | 1999-02-22 |
| SE9900615L (sv) | 2000-08-23 |
| ATE315107T1 (de) | 2006-02-15 |
| JP2002537779A (ja) | 2002-11-12 |
| EP1155153A1 (de) | 2001-11-21 |
| WO2000050645A1 (en) | 2000-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6420106B1 (en) | Method and kit for early cancer prediction | |
| DE69830927T2 (de) | Bewertung von humaner papillomvirus verwandter krankheit | |
| Peng et al. | Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China | |
| US8980555B2 (en) | Rapid genotyping analysis and devices thereof | |
| CN112575123B (zh) | 引物组合、探针组合以及人乳头瘤病毒核酸检测试剂盒 | |
| Rostami et al. | High resolution melting technique for molecular epidemiological studies of cystic echinococcosis: differentiating G1, G3, and G6 genotypes of Echinococcus granulosus sensu lato | |
| WO2010102460A1 (zh) | 定性定量检测病原微生物遗传物质的方法及其试剂盒 | |
| WO2022247523A1 (zh) | 一种用于结直肠癌早期诊断的生物标志物组合物及应用 | |
| CN103184294A (zh) | 人乳头瘤病毒(hpv)16,18型多通道荧光pcr检测方法与试剂盒 | |
| CN102102131A (zh) | 检测单纯疱疹病毒ⅱ型荧光pcr试剂盒 | |
| CN104911277B (zh) | 一种检测干血斑标本中人类免疫缺陷病毒1型的试剂盒及其检测方法 | |
| SE515668C2 (sv) | Metod och kit för tidig förutsägelse av cancer | |
| CN105296481B (zh) | 一种基于基因测序法的hla‑b27基因分型的方法 | |
| US7687232B2 (en) | Method for estimating the risk of carcinoma development | |
| CN108486223B (zh) | 一种吉氏巴贝斯虫rpa分子检测方法 | |
| WO2014010806A1 (ko) | 아이피-10 엠 알엔에이 표적 실시간 역전사효소 중합반응을 이용한 결핵의 진단을 위한 정보제공방법 및 이를 위한 결핵 진단용 키트 | |
| KR101401940B1 (ko) | 고위험군 인유두종바이러스 유전자 분석용 키트 및 그 분석방법 | |
| US20240068058A1 (en) | HPV Detection from urine analyte in male, non-binary and transgender patients | |
| Dobec et al. | Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland | |
| CN117568501A (zh) | 基于实时荧光定量pcr技术检测蛇源隐孢子虫的引物探针组合、试剂盒及方法 | |
| Anderson | Human papillomavirus and cervical cancer | |
| CN117987597A (zh) | 病毒性角结膜炎hsv-1/2和vzv多重检测试剂盒及检测方法 | |
| CN110923307A (zh) | 用于检测hla-b*27等位基因的试剂盒、组合物及方法 | |
| Matsui et al. | Direct detection of hepatitis B virus gene integrated in the Alexander cell using fluorescence in situ polymerase chain reaction | |
| KR20110116644A (ko) | 결핵의 진단을 위한 정보제공방법 및 이를 위한 결핵 진단용 키트 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |